期刊文献+

硫酸吗啡口腔崩解片的制备及处方工艺研究 被引量:4

Study on Preparation and Formulation Technology of Morphine Sulfate Oral Disintegrating Tablets
原文传递
导出
摘要 目的:制备硫酸吗啡口腔崩解片,优化其处方工艺条件。方法:采用直接压片法制备硫酸吗啡口腔崩解片,以崩解时间和口感为指标采用单因素试验法筛选片剂硬度、硬脂酸镁用量、甜菊苷用量范围等,再以崩解时限为指标采用星点设计法优化微晶纤维素(SMCC)、交联羧甲基纤维素钠(CCMC-Na)、甜菊苷用量,并对最优处方所制制剂进行验证。结果:最优处方组成为(片质量60 mg):硫酸吗啡16.67%、SMCC 35.77%、CCMC-Na 8.94%、甜菊苷2.85%、硬脂酸镁1%、甘露醇34.77%。所制口腔崩解片硬度为3 kg,能在12 s内完全崩解,且味微甜、口感良好。结论:该制剂制备方法简便、可行。 OBJECTIVE: To prepare Morphine sulfate oral disintegrating tablets, and to optimize its formulation technology. METHODS: Morphine sulfate oral disintegrating tablet was prepared with direct compression process. The solidity of tablet, the amount of magnesium stearate and the amount range of stevioside were screened with single factor test using disintegration time and taste as index. The amounts of SMCC, CCMC-Na and stevioside were optimized by central composite design using disintegration time as index. The preparation prepared by optimized formulation was validated. RESULTS: The optimal formulation (60 mg/tablet) was as follows: morphine sulfate 16.67%, SMCC 35.77%, CCMC-Na 8.94%, stevia glycosides 2.85%, magnesium stearate 1%, manmitol 34.77%. The prepared tablets were 3 kg in solidity, and disintegrated completely within 12 s, with desirable taste and a little sweet. CONCLUSIONS: The preparation method is simple and feasible.
出处 《中国药房》 CAS CSCD 2014年第37期3493-3496,共4页 China Pharmacy
基金 国家科技重大专项课题(No.2008ZXJ09004-042)
关键词 硫酸吗啡口腔崩解片 直接压片法 单因素试验 星点设计 Morphine sulfate oral disintegrating tablets Direct compression process Single factor test Central composite design
  • 相关文献

参考文献8

  • 1四川美康医药软件研究有限公司.药物临床信息参考[M].重庆:重庆出版社,2008:1 372-1 374.
  • 2国家食品药品监督管理局审评四部药学组.口腔崩解片的剂型特点和质量控制会议纪要[EB/OL]. (2003-08-02) [2013-12—15] .http : //www.chinabaike.com/z/yiqi/2011/0327/634443.html.
  • 3吴伟,崔光华,陆彬.实验设计中多指标的优化:星点设计和总评“归一值”的应用[J].中国药学杂志,2000,35(8):530-533. 被引量:311
  • 4NCCN Adult Cancer Panel Member. NCCN clinical prac-tice guidelines in oncology[EB/OL]. (2009) [2013-12-25].http : //wenku.baidu.com/link.url=pLUlY8BuLxj2JAc-Wer9cLf47zm8AhcZjhOrdfVxunU39tXBNtyUJOUk2Jlv-VXTh6Md_9SPzDIB95Ffxk-t3kepJVOdd64qJHA8816ai-luYK.
  • 5卫生部.癌症三级止痛阶梯疗法指导原则[EB/OL]_(1993-05) [2013-12-25].http://www.cnki.com.cn/Article/CJFD-Total-ZGYS199304000.htm.
  • 6Sugimoto M,Narisawa S,Matsubara K,et al. Developme-nt of manufacturing method for rapidly disintegrating oraltablets using the crystalline transition of amorphous su-crose[J]. IntJPharm,2006,320( 1/2) :71.
  • 7黄朝霞.粉末直接压片工艺的进展[J].现代食品与药品杂志,2007,17(5):31-36. 被引量:31
  • 8何朝星,何函星,王静,曹德英.掩味技术在口腔崩解片中的应用概况[J].中国药房,2011,22(45):4297-4300. 被引量:6

二级参考文献45

共引文献346

同被引文献50

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部